Wearable Devices

Munich – September 07, 2026 -- Huawei gave an early preview of its next-generation ambulatory blood pressure watch, the HUAWEI WATCH D3, at the European Society of Cardiology Congress in Munich, ahead of its official unveiling at the Huawei Innovative Product Launch on September 2.

Huawei's wrist blood pressure tech dates back to 2021.

The company entered the sports and health sector in 2014, gradually adding heart rate monitoring, SpO2 tracking and ECG recording before launching the HUAWEI WATCH D in 2021 -- its first wrist-worn ambulatory blood pressure monitor, certified as a medical device in China and the European Union. The HUAWEI WATCH D2 followed in 2024 with 24-hour ambulatory blood pressure monitoring.

Berlin – September 07, 2026 -- RingConn will let visitors try its Gen 3 Smart Ring at IFA 2026 in Hall 14, Booth 121, from September 4 to September 8, with the device also featured at ShowStoppers.

The Gen 3 ring has already earned strong ratings from German outlets CHIP.de and connect.de for its health-tracking capabilities.

The ring analyzes vascular trends after calibration with blood pressure readings

Gen 3's headline feature tracks changes in vascular strain over time. Once calibrated against externally measured blood pressure values, the ring's sensors monitor how vascular strain shifts across days and weeks. RingConn notes the product is not intended to diagnose, treat, or prevent disease and does not replace medical advice.